NASDAQ: RDGTRidgetech Inc Stock
$1.01+0.19 (+23.17%)
Updated Sep 16, 2026
RDGT Price
$1.01
Fair Value Price
N/A
Market Cap
$896.15k
52 Week Low
$0.67
52 Week High
$760.50
P/E
-0.06x
P/B
0.02x
P/S
0x
PEG
N/A
Dividend Yield
N/A
Revenue
$132.16M
Earnings
-$1.25M
Gross Margin
3.6%
Operating Margin
-0.97%
Profit Margin
-0.9%
Debt to Equity
0.69
Operating Cash Flow
-$1M
Beta
1.05
Next Earnings
Oct 30, 2026
Ex-Dividend
N/A
Next Dividend
N/A
RDGT Overview
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RDGT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Pharmaceutical Retailer
Industry Rating
C
RDGT
Ranked#2 of 2
Ranked#2 of 2
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $2.69 | C | |
| $0.12 | – | |
| $1.60 | – |
Be the first to know about important RDGT news, forecast changes, insider trades & much more!
RDGT News
Overview
Due Diligence Score
–
Industry Average (18)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RDGT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RDGT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RDGT is good value based on its book value relative to its share price (0.02x), compared to the US Pharmaceutical Retailers industry average (15.85x)
P/B vs Industry Valuation
RDGT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RDGT due diligence checks available for Premium users.
Valuation
RDGT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.06x
Industry
-6.46x
Market
44.18x
RDGT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.02x
Industry
15.85x
RDGT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RDGT's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
RDGT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
RDGT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$69.0M
Liabilities
$28.3M
Debt to equity
0.69
RDGT's short-term assets ($64.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RDGT's short-term assets ($64.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RDGT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RDGT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
RDGT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
RDGT vs Pharmaceutical Retailer Stocks
Ridgetech Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.